RICEBRAN TECHNOLOGIES (NASDAQ:RIBT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

0

RICEBRAN TECHNOLOGIES (NASDAQ:RIBT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Item 5.02

Departure of Directors or Principal Officers; Election of
Directors; Appointment of Principal Officers.
Appointment of Brent R. Rystrom as Chief Financial Officer of
RiceBran Technologies
On March 8, 2017, Brent R. Rystrom, 53, was appointed Chief
Financial Officer of RiceBran Technologies (the Company). Mr.
Rystrom brings over 25 years of business finance experience,
including over 20 years of service as a Director of Research and
Senior Financial Analyst for several prominent investment banking
firms, including Piper Jaffray and Feltl Company. From 2009 until
joining RiceBran Technologies, Mr. Rystrom served as Director of
Research for Feltl Company, a regional investment banking firm
headquartered in Minnesota. While at Feltl, he managed the firms
research, institutional sales, and trading departments while
providing research coverage on consumer products, retail and
agriculture companies ranging from micro to large capitalization.
Over his 11 years of service at Piper Jaffray he was named a Wall
Street Journal Best on the Street analyst and a Top 10 Retailing
Industry Analyst from Reuters. Since 1997, Mr. Rystrom has also
successfully acquired and managed a large portfolio of personal
agricultural real estate assets, and from 2011 through 2015, he
served on the Customer Advisory Board of AgStar, a $10 billion
agricultural bank based in Minnesota. Mr. Rystrom holds a Degree
in Business-Finance from St. Thomas University. Mr. Rystrom and
the Company entered into an employment agreement on March 8, 2017
(the Employment Agreement). The Employment Agreement has a term
ending on December 31, 2017. to the Employment Agreement, the
Company agreed to pay Mr. Rystrom an annual salary of $200,000
and a signing fee of $25,000 and agreed to reimburse Mr. Rystrom
for his relocation expenses up to $40,000. Mr. Rystrom is
eligible to participate in any Company annual bonus program
applicable to senior officers and approved by the Companys
Compensation Committee.
If the employment of Mr. Rystrom is terminated by the Company
without cause (as defined in the Employment Agreement) or is
terminated by Mr. Rystrom with good reason (as defined in the
Employment Agreement), then Mr. Rystrom will be entitled to
receive an amount equal to all previously accrued but unpaid
compensation and the base salary that Mr. Rystrom would have been
paid for 90 days following notice of termination or resignation.
In addition, if Mr. Rystroms employment terminates within 60 days
before to 90 days after a change of control transaction (as
defined in the Employment Agreement), Mr. Rystrom will be
entitled to receive an amount equal to 180 days of his then
effective base salary.
The description of the terms of the Employment Agreement does not
purport to be complete and is qualified in its entirety to the
full text of the Employment Agreement, which is attached hereto
as Exhibit 10.1 and incorporated by reference herein.
In connection with Mr. Rystroms appointment, Jerry Dale Belts
position as the Companys Chief Financial Officer terminated,
effective as of March 8, 2017. Mr. Belt will remain with the
Company and serve as the Companys Executive Vice President of
Special Projects. On March 8, 2017, Mr. Belt also entered into an
amendment to his employment agreement that extended his term of
employment through December 31, 2017.
Amendments to the Employment Agreement for Dr. Robert
Smith
On March 8, 2017, the employment agreement for Dr. Robert Smith,
the Companys Chief Executive Officer, was amended to extend his
term of employment from June 1, 2017 to December 31, 2017, to
reflect his current title and base annual salary of $250,000 and
to provide for the March 8, 2017 grant to Dr. Smith of an option
to purchase 100,000 shares of the Companys common stock to the
Companys 2014 Equity Incentive Plan. The full text of the
employment agreement, as amended, is filed as Exhibit 10.2 to
this Current Report on Form 8-K and incorporated by reference
herein.
Item 9.01
Financial Statements and Exhibits.
Exhibit

No.

Description
10.1
Employment Agreement with Brent R. Rystrom dated March 8,
2017
10.2
Amended and Restated Employment Agreement with Robert Smith
dated as of March 8, 2017


About RICEBRAN TECHNOLOGIES (NASDAQ:RIBT)

RiceBran Technologies is a human food ingredient, functional food ingredient, packaged functional food and animal nutrition company. The Company is focused on processing and marketing of nutrient dense products derived from raw rice, an underutilized by-product of the rice milling industry. The Company has two operating segments. The USA segment manufactures and distributes stabilized rice bran (SRB) (for human food ingredient and animal nutrition customers) and derivative products. The Brazil segment extracts crude rice bran oil (RBO) and defatted rice bran (DRB) from rice bran, which are then further processed into fully refined rice bran oil for sale internationally and in Brazil, compounded animal nutrition products for horses, cows, swine, sheep and poultry and a range of human food and animal nutrition products. The Brazil segment consists of the operations of Nutra S.A. LLC subsidiary, whose only operating subsidiary is Industria Riograndens De Oleos Vegetais Ltda. (Irgovel).

RICEBRAN TECHNOLOGIES (NASDAQ:RIBT) Recent Trading Information

RICEBRAN TECHNOLOGIES (NASDAQ:RIBT) closed its last trading session up +0.020 at 0.780 with shares trading hands.